Literature DB >> 32281944

The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.

Darshana Kadekar1, Rasmus Agerholm1, John Rizk1, Heidi A Neubauer2, Tobias Suske2, Barbara Maurer2, Monica Torrellas Viñals1, Elena M Comelli3,4, Amel Taibi3, Richard Moriggl2, Vasileios Bekiaris1.   

Abstract

IL-17-producing RORγt+ γδ T cells (γδT17 cells) are innate lymphocytes that participate in type 3 immune responses during infection and inflammation. Herein, we show that γδT17 cells rapidly proliferate within neonatal lymph nodes and gut, where, upon entry, they upregulate T-bet and coexpress IL-17, IL-22, and IFN-γ in a STAT3- and retinoic acid-dependent manner. Neonatal expansion was halted in mice conditionally deficient in STAT5, and its loss resulted in γδT17 cell depletion from all adult organs. Hyperactive STAT5 mutant mice showed that the STAT5A homolog had a dominant role over STAT5B in promoting γδT17 cell expansion and downregulating gut-associated T-bet. In contrast, STAT5B preferentially expanded IFN-γ-producing γδ populations, implying a previously unknown differential role of STAT5 gene products in lymphocyte lineage regulation. Importantly, mice lacking γδT17 cells as a result of STAT5 deficiency displayed a profound resistance to experimental autoimmune encephalomyelitis. Our data identify that the neonatal microenvironment in combination with STAT5 is critical for post-thymic γδT17 development and tissue-specific imprinting, which is essential for infection and autoimmunity.

Entities:  

Keywords:  Cellular immune response; Immunology; T cell development; T cells

Year:  2020        PMID: 32281944      PMCID: PMC7190909          DOI: 10.1172/JCI131241

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  Growth hormone insensitivity associated with a STAT5b mutation.

Authors:  Eric M Kofoed; Vivian Hwa; Brian Little; Katie A Woods; Caroline K Buckway; Junko Tsubaki; Katherine L Pratt; Liliana Bezrodnik; Hector Jasper; Alejandro Tepper; Juan J Heinrich; Ron G Rosenfeld
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

2.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

4.  A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.

Authors:  Ziad Al Nabhani; Sophie Dulauroy; Rute Marques; Clara Cousu; Shahed Al Bounny; François Déjardin; Tim Sparwasser; Marion Bérard; Nadine Cerf-Bensussan; Gérard Eberl
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

5.  Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells.

Authors:  Gleb Turchinovich; Adrian C Hayday
Journal:  Immunity       Date:  2011-07-07       Impact factor: 31.745

6.  Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

Authors:  Arian Laurence; Cristina M Tato; Todd S Davidson; Yuka Kanno; Zhi Chen; Zhengju Yao; Rebecca B Blank; Françoise Meylan; Richard Siegel; Lothar Hennighausen; Ethan M Shevach; John J O'shea
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

Review 7.  STAT5B deficiency: Impacts on human growth and immunity.

Authors:  Vivian Hwa
Journal:  Growth Horm IGF Res       Date:  2015-12-10       Impact factor: 2.372

8.  Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.

Authors:  Nicholas C P Cross; Yvette Hoade; William J Tapper; Gonzalo Carreno-Tarragona; Tiziana Fanelli; Mohamad Jawhar; Nicole Naumann; Iwo Pieniak; Johannes Lübke; Sahra Ali; Kaljit Bhuller; Sonja Burgstaller; Catherine Cargo; Jamie Cavenagh; Andrew S Duncombe; Emma Das-Gupta; Paul Evans; Peter Forsyth; Philip George; Charlotte Grimley; Fergus Jack; Laura Munro; Varun Mehra; Kavita Patel; Ali Rismani; Gabriela Sciuccati; Rowena Thomas-Dewing; Patrick Thornton; Andres Virchis; Simon Watt; Louise Wallis; Alastair Whiteway; Kris Zegocki; Barbara J Bain; Andreas Reiter; Andrew Chase
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

9.  Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.

Authors:  Heather R Conti; Alanna C Peterson; Lucas Brane; Anna R Huppler; Nydiaris Hernández-Santos; Natasha Whibley; Abhishek V Garg; Michelle R Simpson-Abelson; Gregory A Gibson; Anna J Mamo; Lisa C Osborne; Shrinivas Bishu; Nico Ghilardi; Ulrich Siebenlist; Simon C Watkins; David Artis; Mandy J McGeachy; Sarah L Gaffen
Journal:  J Exp Med       Date:  2014-09-08       Impact factor: 14.307

Review 10.  JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.

Authors:  William Vainchenker; Emilie Leroy; Laure Gilles; Caroline Marty; Isabelle Plo; Stefan N Constantinescu
Journal:  F1000Res       Date:  2018-01-17
View more
  3 in total

1.  TOX deficiency facilitates the differentiation of IL-17A-producing γδ T cells to drive autoimmune hepatitis.

Authors:  Qifeng He; Yijun Lu; Wenfang Tian; Runqiu Jiang; Weiwei Yu; Yong Liu; Meiling Sun; Fei Wang; Haitian Zhang; Ning Wu; Zhongjun Dong; Beicheng Sun
Journal:  Cell Mol Immunol       Date:  2022-08-19       Impact factor: 22.096

Review 2.  A centric view of JAK/STAT5 in intestinal homeostasis, infection, and inflammation.

Authors:  Marta Surbek; William Tse; Richard Moriggl; Xiaonan Han
Journal:  Cytokine       Date:  2021-01-19       Impact factor: 3.861

Review 3.  The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

Authors:  Susann Schönefeldt; Tamara Wais; Marco Herling; Satu Mustjoki; Vasileios Bekiaris; Richard Moriggl; Heidi A Neubauer
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.